Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help ensure timely (a) approval and (b) delivery of Novavax vaccine for immunosuppressed people.

The Medicines and Healthcare products Regulatory Agency has now approved an adapted version of the Nuvaxovid COVID-19 vaccine that targets the Omicron JN.1 COVID-19 subvariant. The press release is available at the following link:

https://www.gov.uk/government/news/mhra-approves-adapted-nuvaxovid-jn1-covid-19-vaccines-for-adults-and-children-aged-12-plus

The UK Health Security Agency is unable to comment on any ongoing procurement activity for future campaigns due to commercial sensitivities.